Literature DB >> 4625396

Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis.

C J Peters, K M Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4625396      PMCID: PMC1553662     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  THE CHANGES IN THE SERUM PROTEINS IN PATIENTS WITH EXPERIMENTALLY INDUCED INFECTIOUS HEPATITIS.

Authors:  W P Havens; T L Williams
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

2.  Immunoglobulins and interferon responses in infectious and transfusion associated hepatitis.

Authors:  G A LoGrippo; H Hayashi; N Sharpless
Journal:  Henry Ford Hosp Med J       Date:  1967-03

3.  Serum immunoglobulin levels in blood donors implicated in transmission of hepatitis.

Authors:  G Bevan; H F Taswell; G J Gleich
Journal:  JAMA       Date:  1968-01-01       Impact factor: 56.272

4.  Immunoglobulin levels in detection of viral hepatitis.

Authors:  R L Peters; M Ashcavai
Journal:  Am J Clin Pathol       Date:  1970-07       Impact factor: 2.493

5.  Viral hepatitis. Immunoglobulin response during the course of the disease.

Authors:  J P Giles; S Krugman
Journal:  JAMA       Date:  1969-04-21       Impact factor: 56.272

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

8.  Immunoglobulins in viral hepatitis and active alcoholic liver-disease.

Authors:  F I Lee
Journal:  Lancet       Date:  1965-11-20       Impact factor: 79.321

9.  A complement-fixation test for measuring Australia antigen and antibody.

Authors:  R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

10.  Biosynthesis of low molecular weight (7S) and high molecular weight (19S) immunoglobulin M.

Authors:  A Solomon; C L McLaughlin
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

View more
  8 in total

1.  Fulminant hepatitis associated with acquired defect in humoral immunity.

Authors:  J Greally; J Dillon; B Mayne
Journal:  Ir J Med Sci       Date:  1974-11       Impact factor: 1.568

2.  Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

Authors:  F J Dudley; M J O'Shea; A Ajdukiewicz; S Sherlock
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

3.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

4.  Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection.

Authors:  A Vierucci; M de Martino; M E Rossi; C Vullo; L Borgatti; W T London; B S Blumberg
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

5.  Increased total serum IgE concentration in patients who have undergone splenectomy after trauma.

Authors:  G Chelazzi; G Pinotti; C Nicora; D Rossi; G Senaldi
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

6.  Autoimmune implications of immune complexes in clinical variants of hepatitis B.

Authors:  H Daugharty; K Kelley; C Moore; T Hersh
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

7.  IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia.

Authors:  W H Dietz; O Porcell; T E Moon; C J Peters; R H Purcell
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

8.  Immune reactions in acute viral hepatitis.

Authors:  D I Newble; K T Holmes; A G Wangel; I J Forbes
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.